Guangdong Zhongsheng Pharmaceutical Co., Ltd.
002317
Rankning i aktier
#4566
Guangdong Zhongsheng Pharmaceutical Co., Ltd. is a Chinese pharmaceutical... Guangdong Zhongsheng Pharmaceutical Co., Ltd. is a Chinese pharmaceutical company actively involved in the entire lifecycle of drug development, from research and development to manufacturing and commercialization. Its product portfolio encompasses both traditional Chinese medicines (TCM) and modern chemical pharmaceuticals. The company's robust research and development initiatives are directed towards creating solutions for a wide array of health conditions, specifically targeting ophthalmological, cardiovascular, cerebrovascular, respiratory, digestive, diabetic, oncological, and age-related degenerative diseases. Established in 1979, the company maintains its primary operations from its headquarters in Dongguan, China.
Aktiekurs
$3.89
Marknadsvärde
$3.30B
Förändring (1 dag)
-3.14%
Förändring (1 år)
43.11%
Land
CN
Handel Guangdong Zhongsheng Pharmaceutical Co., Ltd. (002317)
Kategori
Healthcare
Vinst för Guangdong Zhongsheng Pharmaceutical Co., Ltd. (002317)
Vinst i Jun 2026 TTM: $30.61M
Enligt de senaste finansiella rapporterna från Guangdong Zhongsheng Pharmaceutical Co., Ltd. är företagets nuvarande vinst $30.61M. År 2024 hade företaget en vinst på $-46.02M, en minskning jämfört med vinsten år 2023 som var $40.07M. Vinsten som visas på denna sida är vinsten före räntor och skatt, även kallad EBIT.
Vinshistorik för Guangdong Zhongsheng Pharmaceutical Co., Ltd. från 2006 till 2026
Vinst vid slutet av varje år
| År | Vinst | Ändra |
|---|---|---|
| 2026 (TTM) | $30.61M | -27.78% |
| 2025 | $42.39M | -192.12% |
| 2024 | $-46.02M | -214.83% |
| 2023 | $40.07M | -24.95% |
| 2022 | $53.39M | 9.66% |
| 2021 | $48.69M | -192.13% |
| 2020 | $-52.85M | -197.14% |
| 2019 | $54.41M | -25.14% |
| 2018 | $72.68M | -3.83% |
| 2017 | $75.58M | 8.55% |
| 2016 | $69.62M | 32.24% |
| 2015 | $52.65M | 31.36% |
| 2014 | $40.08M | 11.54% |
| 2013 | $35.94M | 5.30% |
| 2012 | $34.13M | 22.83% |
| 2011 | $27.78M | 19.74% |
| 2010 | $23.20M | 38.06% |
| 2009 | $16.81M | 34.21% |
| 2008 | $12.52M | 76.32% |
| 2007 | $7.10M | 52.00% |
| 2006 | $4.67M | 0.00% |
Vinst för liknande företag eller konkurrenter
| Företag | Vinst | Skillnad i vinst | Land |
|---|---|---|---|
| $3.62B | 11,717.83% |
DE
|
|
| $3.40B | 11,022.45% |
DE
|
|
| $1.72B | 5,530.23% |
JP
|
|
| $930.30M | 2,938.85% |
CH
|
|
| $1.69B | 5,429.10% |
IN
|
